Comment on 'Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study'.

Johnson, Chandler; Smith, Payton; Haran, Kathryn; Kranyak, Allison; Liao, Wilson; Bhutani, Tina

Johnson, Chandler; Smith, Payton; Haran, Kathryn; Kranyak, Allison; Liao, Wilson; Bhutani, Tina.

Affiliation

Johnson C; Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.
Smith P; Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.
Haran K; Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.
Kranyak A; Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.
Liao W; Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.
Bhutani T; Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.

Br J Dermatol ; 190(4): 596, 2024 Mar 15.

Article in En | MEDLINE | ID: mdl-38149911

Subject(s)

Dermatitis, Atopic; Adult; Humans; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized/therapeutic use; Dermatitis, Atopic/drug therapy; Double-Blind Method; Sleep; Clinical Trials, Phase IV as Topic; Randomized Controlled Trials as Topic

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic Limits: Adult / Humans Language: En Journal: Br J Dermatol Year: 2024 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google